Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Implication of TIGIT+ human memory B cells in immune regulation
Md. Mahmudul Hasan, S. Nair, Jacqueline G. O’Leary, et al.
Nature Communications (2021) Vol. 12, Iss. 1
Open Access | Times Cited: 60

Showing 1-25 of 60 citing articles:

Targeting LAG-3, TIM-3, and TIGIT for cancer immunotherapy
Letong Cai, Yuchen Li, Jiaxiong Tan, et al.
Journal of Hematology & Oncology (2023) Vol. 16, Iss. 1
Open Access | Times Cited: 129
B-cell-specific checkpoint molecules that regulate anti-tumour immunity
Lloyd Bod, Yoon-Chul Kye, Jingwen Shi, et al.
Nature (2023) Vol. 619, Iss. 7969, pp. 348-356
Closed Access | Times Cited: 96
LAG-3, TIM-3, and TIGIT: Distinct functions in immune regulation
Nicole Joller, Ana C. Anderson, Vijay K. Kuchroo
Immunity (2024) Vol. 57, Iss. 2, pp. 206-222
Open Access | Times Cited: 52
Targeting TIGIT for cancer immunotherapy: recent advances and future directions
Peng Zhang, Xinyuan Liu, Zhuoyu Gu, et al.
Biomarker Research (2024) Vol. 12, Iss. 1
Open Access | Times Cited: 32
Development of pharmacological immunoregulatory anti-cancer therapeutics: current mechanistic studies and clinical opportunities
Nanhao Yin, Xintong Li, Xuanwei Zhang, et al.
Signal Transduction and Targeted Therapy (2024) Vol. 9, Iss. 1
Open Access | Times Cited: 20
Human IL-10-producing B cells have diverse states that are induced from multiple B cell subsets
Marla C. Glass, David R. Glass, John-Paul Oliveria, et al.
Cell Reports (2022) Vol. 39, Iss. 3, pp. 110728-110728
Open Access | Times Cited: 54
The Role of Coinhibitory Receptors in B Cell Dysregulation in SARS-CoV-2–Infected Individuals with Severe Disease
Suguru Saito, Najmeh Bozorgmehr, Wendy Sligl, et al.
The Journal of Immunology (2024) Vol. 212, Iss. 10, pp. 1540-1552
Open Access | Times Cited: 9
Immune checkpoint inhibitors and reproductive failures
Zeyang Chen, Jinxia Huang, Joanne Kwak‐Kim, et al.
Journal of Reproductive Immunology (2023) Vol. 156, pp. 103799-103799
Closed Access | Times Cited: 22
Current insights into the hepatic microenvironment and advances in immunotherapy for hepatocellular carcinoma
Minglei Zhao, Hui Huang, Feng He, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 17
Role of Treg cell subsets in cardiovascular disease pathogenesis and potential therapeutic targets
Yuanliang Xia, Di Gao, Xu Wang, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 7
Temporal dynamics and genomic programming of plasma cell fates
Godhev K. Manakkat Vijay, Ming Zhou, Kairavee Thakkar, et al.
Nature Immunology (2024) Vol. 25, Iss. 6, pp. 1097-1109
Closed Access | Times Cited: 6
Impaired TIGIT expression on B cells drives circulating follicular helper T cell expansion in multiple sclerosis
Hiromitsu Asashima, Pierre‐Paul Axisa, Thi Hong Giang Pham, et al.
Journal of Clinical Investigation (2022) Vol. 132, Iss. 20
Open Access | Times Cited: 26
TIGIT as a Promising Therapeutic Target in Autoimmune Diseases
Chenran Yue, Sheng Gao, Shuting Li, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 24
Peritumoral TIGIT+CD20+ B cell infiltration indicates poor prognosis but favorable adjuvant chemotherapeutic response in gastric cancer
Huifang Liu, Jing Wu, Xiaoyu Xu, et al.
International Immunopharmacology (2022) Vol. 108, pp. 108735-108735
Open Access | Times Cited: 23
Ex vivo-expanded human CD19+TIM-1+ regulatory B cells suppress immune responses in vivo and are dependent upon the TIM-1/STAT3 axis
Sushma Shankar, Jessica Stolp, S. Juvet, et al.
Nature Communications (2022) Vol. 13, Iss. 1
Open Access | Times Cited: 23
A potential area of use for immune checkpoint inhibitors: Targeting bone marrow microenvironment in acute myeloid leukemia
Başak Aru, Cemil Pehlivanoğlu, Zeynep Dal, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 13
TIGIT: An emerging immune checkpoint target for immunotherapy in autoimmune disease and cancer
Junpeng Zhao, Liming Li, Huiqi Yin, et al.
International Immunopharmacology (2023) Vol. 120, pp. 110358-110358
Closed Access | Times Cited: 13
TIGIT agonism alleviates costimulation blockade-resistant rejection in a regulatory T cell–dependent manner
Christina R. Hartigan, Katherine P Tong, Danya Liu, et al.
American Journal of Transplantation (2023) Vol. 23, Iss. 2, pp. 180-189
Open Access | Times Cited: 12
Recognizing Complexity of CD8 T Cells in Transplantation
Michael Nicosia, Anna Valujskikh
Transplantation (2024) Vol. 108, Iss. 11, pp. 2186-2196
Closed Access | Times Cited: 4
The current understanding of the phenotypic and functional properties of human regulatory B cells (bregs)
Nawara Faiza Ahsan, Stella Lourenço, Dimitra Psyllou, et al.
Oxford Open Immunology (2024) Vol. 5, Iss. 1
Open Access | Times Cited: 4
Emerging roles of checkpoint molecules on B cells
Hiromitsu Asashima, Satoshi Akao, Isao Matsumoto
Immunological Medicine (2025), pp. 1-12
Open Access
Multifaceted function of B cells in tumorigenesis
Na Kang, Qinghui Duan, Xin Min, et al.
Frontiers of Medicine (2025)
Closed Access
Computational screening for natural compounds as potential immune checkpoint inhibitors against TIGIT, a new avenue in cancer immunotherapy
Aritra Chakraborty, Amit Kumar
Molecular Diversity (2025)
Closed Access
Regulatory B cells, the key regulator to induce immune tolerance in organ transplantation
Jinfeng Liao, Yixin Yang, Jisong Li, et al.
Frontiers in Immunology (2025) Vol. 16
Open Access
Promising New Anti‐TIGIT Agents: Stealthy Allies in Cancer Immunotherapy
G. Srikanth, Durga Prasad Beda, Ashish Ranjan Dwivedi, et al.
Clinical and Translational Science (2025) Vol. 18, Iss. 4
Open Access
Page 1 - Next Page

Scroll to top